Nevro Debt to Equity Ratio 2013-2018 | NVRO
Current and historical debt to equity ratio values for Nevro (NVRO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Nevro debt/equity for the three months ending December 31, 2018 was 0.62.
| Nevro Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2018-12-31 | $0.15B | $0.25B | 0.62 |
| 2018-09-30 | $0.15B | $0.24B | 0.62 |
| 2018-06-30 | $0.15B | $0.25B | 0.61 |
| 2018-03-31 | $0.15B | $0.24B | 0.61 |
| 2017-12-31 | $0.15B | $0.25B | 0.58 |
| 2017-09-30 | $0.14B | $0.24B | 0.59 |
| 2017-06-30 | $0.14B | $0.24B | 0.59 |
| 2017-03-31 | $0.14B | $0.24B | 0.58 |
| 2016-12-31 | $0.14B | $0.25B | 0.56 |
| 2016-09-30 | $0.14B | $0.25B | 0.55 |
| 2016-06-30 | $0.14B | $0.25B | 0.55 |
| 2016-03-31 | $0.02B | $0.23B | 0.09 |
| 2015-12-31 | $0.02B | $0.24B | 0.08 |
| 2015-09-30 | $0.02B | $0.24B | 0.08 |
| 2015-06-30 | $0.02B | $0.26B | 0.08 |
| 2015-03-31 | $0.02B | $0.16B | 0.12 |
| 2014-12-31 | $0.02B | $0.17B | 0.11 |
| 2014-09-30 | $0.00B | $-0.11B | 0.00 |
| 2014-06-30 | $0.00B | $0.00B | 0.00 |
| 2014-03-31 | $0.00B | $0.00B | 0.00 |
| 2013-12-31 | $0.00B | $0.00B | 0.00 |
| 2013-09-30 | $0.00B | $0.00B | 0.00 |
| 2012-12-31 | $0.00B | $-0.06B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.863B | $0.387B |
| Nevro Corp. is a medical device company. It engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain. The Company provides pain relief to the customers suffering from low back pain and types of chronic pains. Nevro has developed and commercialized the Senza (R) spinal cord stimulation (SCS) system for the treatment of chronic pain. Senza, HF10, Nevro and the Nevro logo are trademarks of the company. Nevro Corp. is headquartered in Menlo Park, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $104.363B | 22.88 |
| Intuitive Surgical (ISRG) | United States | $58.664B | 54.06 |
| Edwards Lifesciences (EW) | United States | $36.977B | 37.03 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $24.585B | 16.83 |
| IDEXX Laboratories (IDXX) | United States | $19.324B | 52.60 |
| Hologic (HOLX) | United States | $13.031B | 19.70 |
| Teleflex (TFX) | United States | $12.848B | 28.14 |
| ABIOMED (ABMD) | United States | $12.211B | 80.60 |
| Varian Medical Systems (VAR) | United States | $12.098B | 30.92 |
| DexCom (DXCM) | United States | $10.817B | 409.72 |
| STERIS (STE) | United Kingdom | $10.794B | 27.74 |
| Masimo (MASI) | United States | $6.762B | 41.98 |
| Penumbra (PEN) | United States | $4.621B | 261.47 |
| Globus Medical (GMED) | United States | $4.518B | 27.42 |
| Integra LifeSciences Holdings (IART) | United States | $4.381B | 20.62 |
| Wright Medical Group (WMGI) | Netherlands | $3.656B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $3.471B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.338B | 20.57 |
| Cantel Medical (CMD) | United States | $2.780B | 27.65 |
| Glaukos (GKOS) | United States | $2.585B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.241B | 18.22 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.994B | 21.66 |
| Inogen (INGN) | United States | $1.829B | 36.26 |
| OPKO Health (OPK) | United States | $1.436B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $1.102B | 0.00 |
| SILK RD MEDICAL (SILK) | United States | $1.091B | 0.00 |
| CryoLife (CRY) | United States | $1.074B | 115.76 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $1.046B | 28.42 |
| Accelerate Diagnostics (AXDX) | United States | $1.029B | 0.00 |
| Luminex (LMNX) | United States | $1.000B | 45.37 |
| Veracyte (VCYT) | United States | $0.960B | 0.00 |
| Shockwave Medical (SWAV) | United States | $0.928B | 0.00 |
| Fluidigm (FLDM) | United States | $0.927B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.922B | 175.00 |
| Intersect ENT (XENT) | United States | $0.917B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.903B | 36.95 |
| Natus Medical (BABY) | United States | $0.837B | 17.36 |
| AxoGen (AXGN) | United States | $0.827B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.768B | 26.81 |
| ViewRay (VRAY) | United States | $0.679B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.559B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.514B | 0.00 |
| TransEnterix (TRXC) | United States | $0.436B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.425B | 44.39 |
| Corindus Vascular Robotics (CVRS) | United States | $0.419B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.405B | 0.00 |
| Si-Bone (SIBN) | United States | $0.397B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.375B | 46.36 |
| Accuray (ARAY) | United States | $0.373B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.350B | 0.00 |
| IRadimed (IRMD) | United States | $0.308B | 65.16 |
| Neuronetics (STIM) | United States | $0.288B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.268B | 0.00 |
| Sientra (SIEN) | United States | $0.252B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.208B | 48.17 |
| SOLITON INC (SOLY) | $0.180B | 0.00 | |
| Nuvectra (NVTR) | United States | $0.171B | 0.00 |
| ConforMIS (CFMS) | United States | $0.161B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.152B | 0.00 |
| EDAP TMS (EDAP) | France | $0.142B | 489.00 |
| Alphatec Holdings (ATEC) | United States | $0.137B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.133B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.116B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.110B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.103B | 0.00 |
| Vermillion (VRML) | United States | $0.100B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.076B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.072B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.065B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.060B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.057B | 0.00 |
| Electromed (ELMD) | United States | $0.047B | 24.61 |
| Xtant Medical Holdings (XTNT) | United States | $0.038B | 0.00 |
| PAVmed (PAVM) | United States | $0.035B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.034B | 0.00 |
| Neovasc (NVCN) | Canada | $0.032B | 0.00 |
| Avinger (AVGR) | United States | $0.032B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.032B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.027B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.026B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.024B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.022B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.020B | 63.67 |
| American Shared Hospital Services (AMS) | United States | $0.016B | 15.11 |
| Dynatronics (DYNT) | United States | $0.016B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.014B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.012B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.010B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.010B | 0.00 |
| Micron Solutions (MICR) | United States | $0.008B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.006B | 0.00 |
| InspireMD (NSPR) | Israel | $0.006B | 0.00 |
| Presbia (LENS) | Ireland | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.002B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
| ALCON INC (ALC) | $0.000B | 0.00 |
